{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:37:09Z","timestamp":1793353029002,"version":"4.5.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Early detection of prostate cancer (PCa) remains a clinical challenge. Plasma proteomics provides a non-invasive tool for identifying individuals at elevated risk prior to symptom onset or PSA elevation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We quantified 1463 plasma proteins in 23\u00a0825 PCa-free men from the UK Biobank (UKB). Participants were split into training and validation sets. Cox regression and Light Gradient Boosting Machine (LightGBM) with forward feature selection were used to identify and rank predictive proteins. Model performance was assessed by area under the receiver operating characteristic curve (AUC) in the validation set, and SHAP values were used to interpret feature contributions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>TSPAN1 and GP2 consistently ranked as top predictors across all analyses. In the training set, both proteins remained significantly associated with PCa risk after Bonferroni correction in multivariable Cox models. LightGBM with forward selection further prioritized TSPAN1 and GP2 as key contributors, and SHAP analysis confirmed their dominant importance. In the validation set, a model combining TSPAN1, GP2, and demographic variables achieved an AUC of 0.728 for overall PCa prediction and 0.760 for 5-year risk. Based on Youden Index\u2013derived thresholds, high-expression groups of TSPAN1 and GP2 were associated with hazard ratios of 1.75 and 1.60, respectively. Longitudinal profiling showed that TSPAN1 levels began rising approximately 9\u00a0years before diagnosis, while GP2 increased from 6\u00a0years prior.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>TSPAN1 and GP2 are promising long-term predictive biomarkers for PCa. A streamlined proteomics-based model may enable individualized risk stratification and inform earlier, less invasive screening strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000002805","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T06:00:29Z","timestamp":1750831229000},"page":"6123-6134","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Prospective cohort study integrating plasma proteomics and machine learning for early risk prediction of prostate cancer"],"prefix":"10.1097","volume":"111","author":[{"given":"Yongming","family":"Chen","sequence":"first","affiliation":[{"name":"Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxin","family":"Long","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjie","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengtong","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiao","family":"Jiang","sequence":"additional","affiliation":[{"name":"Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4770-4449","authenticated-orcid":false,"given":"Ming","family":"Liu","sequence":"additional","affiliation":[{"name":"Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China"},{"name":"Department of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,28]]},"reference":[{"key":"R1-20261030","first-page":"229\u201363","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20261030","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41571-024-00957-0","article-title":"MRI-based stratification reduces the risk of overdiagnosis of prostate cancer","volume":"21","author":"Sidaway","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"R3-20261030","doi-asserted-by":"crossref","first-page":"1153\u201354","DOI":"10.1056\/NEJMe2409985","article-title":"Prostate biopsy in men with an elevated PSA level \u2013 reducing overdiagnosis","volume":"391","author":"Pinsky","year":"2024","journal-title":"N Engl J Med"},{"key":"R4-20261030","doi-asserted-by":"crossref","first-page":"Jc94","DOI":"10.7326\/ANNALS-24-01275-JC","article-title":"Prostate cancer screening with MRI does not differ from PSA only for detection but reduces biopsies and overdiagnosis","volume":"177","author":"Wilt","year":"2024","journal-title":"Ann Intern Med"},{"key":"R5-20261030","doi-asserted-by":"crossref","first-page":"329\u201338","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"R6-20261030","doi-asserted-by":"crossref","first-page":"845\u201367","DOI":"10.1074\/mcp.R200007-MCP200","article-title":"The human plasma proteome: history, character, and diagnostic prospects","volume":"1","author":"Anderson","year":"2002","journal-title":"Mol Cell Proteomics"},{"key":"R7-20261030","doi-asserted-by":"crossref","first-page":"649\u201358","DOI":"10.1001\/jamacardio.2024.1178","article-title":"High throughput plasma proteomics and risk of heart failure and frailty in late life","volume":"9","author":"Ramonfaur","year":"2024","journal-title":"JAMA Cardiol"},{"key":"R8-20261030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13073-024-01395-4","article-title":"Integrating metabolomics and proteomics to identify novel drug targets for heart failure and atrial fibrillation","volume":"16","author":"van Vugt","year":"2024","journal-title":"Genome Med"},{"key":"R9-20261030","doi-asserted-by":"crossref","first-page":"e013037","DOI":"10.1161\/CIRCEP.124.013037","article-title":"Plasma proteomic insights for identification of novel predictors and potential drug targets in atrial fibrillation: a prospective cohort study and Mendelian randomization analysis","volume":"17","author":"Peng","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R10-20261030","doi-asserted-by":"crossref","first-page":"8873","DOI":"10.1038\/s41467-024-52894-2","article-title":"Plasma proteomic and polygenic profiling improve risk stratification and personalized screening for colorectal cancer","volume":"15","author":"Sun","year":"2024","journal-title":"Nat Commun"},{"key":"R11-20261030","doi-asserted-by":"crossref","first-page":"e2402509","DOI":"10.1002\/advs.202402509","article-title":"Proteomic identification of small extracellular vesicle proteins LAMB1 and histone H4 for prostate cancer diagnosis and risk stratification","volume":"11","author":"Pang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"R12-20261030","first-page":"100081","article-title":"Revised strengthening the reporting of cohort, cross-sectional and case-control studies in surgery (STROCSS) guideline: an update for the age of artificial intelligence","volume":"10","author":"Agha","year":"2025","journal-title":"Premier J Sci"},{"key":"R13-20261030","doi-asserted-by":"crossref","first-page":"100168","DOI":"10.1016\/j.mcpro.2021.100168","article-title":"Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis","volume":"20","author":"Wik","year":"2021","journal-title":"Mol Cell Proteomics"},{"key":"R14-20261030","doi-asserted-by":"crossref","first-page":"234\u201344","DOI":"10.1093\/ije\/dym276","article-title":"The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine","volume":"37","author":"Elliott","year":"2008","journal-title":"Int J Epidemiol"},{"key":"R15-20261030","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14:","author":"Chen","year":"2013","journal-title":"BMC Bioinf"},{"key":"R16-20261030","doi-asserted-by":"crossref","first-page":"188674","DOI":"10.1016\/j.bbcan.2021.188674","article-title":"TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance","volume":"1877","author":"Garcia-Mayea","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"R17-20261030","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1038\/s41598-017-05489-5","article-title":"The cancer-associated cell migration protein TSPAN1 is under control of androgens and its upregulation increases prostate cancer cell migration","volume":"7","author":"Munkley","year":"2017","journal-title":"Sci Rep"},{"key":"R18-20261030","doi-asserted-by":"crossref","first-page":"9016","DOI":"10.1038\/s41598-023-36125-0","article-title":"Establishment of cancer-associated fibroblasts-related subtypes and prognostic index for prostate cancer through single-cell and bulk RNA transcriptome","volume":"13","author":"Qian","year":"2023","journal-title":"Sci Rep"},{"key":"R19-20261030","doi-asserted-by":"crossref","first-page":"204\u201312","DOI":"10.1111\/apm.13117","article-title":"Prognostic role of TSPAN1, KIAA1324 and ESRP1 in prostate cancer","volume":"129","author":"Stinnesbeck","year":"2021","journal-title":"Apmis"},{"key":"R20-20261030","doi-asserted-by":"crossref","first-page":"139\u201349","DOI":"10.1097\/00006676-199403000-00001","article-title":"Role of the GP2\/THP family of GPI-anchored proteins in membrane trafficking during regulated exocrine secretion","volume":"9","author":"Scheele","year":"1994","journal-title":"Pancreas"},{"key":"R21-20261030","doi-asserted-by":"crossref","first-page":"154123","DOI":"10.1016\/j.prp.2022.154123","article-title":"Diagnostic and prognostic role of pancreatic secretory granule membrane major glycoprotein 2 (GP2) immunohistochemistry: a TMA study on 27,681 tumors","volume":"238","author":"Uhlig","year":"2022","journal-title":"Pathol Res Pract"},{"key":"R22-20261030","doi-asserted-by":"crossref","first-page":"43\u201348","DOI":"10.1016\/j.tranon.2018.09.003","article-title":"Biomarkers associated with tumor heterogeneity in prostate cancer","volume":"12","author":"Yun","year":"2019","journal-title":"Transl Oncol"},{"key":"R23-20261030","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.euo.2024.11.010","article-title":"Long-term risk of prostate cancer mortality among men with baseline prostate-specific antigen below 3 ng\/ml: evidence from the Finnish Randomized Study of Screening for Prostate Cancer","volume":"8","author":"Ola","journal-title":"Eur Urol Oncol"},{"key":"R24-20261030","first-page":"3722\u201334","article-title":"Transition-zone PSA-density calculated from MRI deep learning prostate zonal segmentation model for prediction of clinically significant prostate cancer","volume":"49","author":"Kuanar","year":"2024","journal-title":"Abdom Radiol (NY)"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000002805","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:04:09Z","timestamp":1793351049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000002805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,28]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000002805","relation":{},"ISSN":["1743-9159","1743-9191"],"issn-type":[{"value":"1743-9159","type":"electronic"},{"value":"1743-9191","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,28]]},"assertion":[{"value":"2025-04-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}